Clinical Trial Update: Treatment of the Bilateral Severe Uveitis by IVT of Regulator T-cells: Study of Tolerance of Dose [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating intravenous regulatory T-cell therapy for bilateral severe uveitis; the study is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Regulatory T cell therapy (regulatory T cells)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Uveitis | Phase 1, Phase 2 | Status: SUSPENDED